A systematic review and meta-analysis of clinical trials of thyroid hormone administration to brain dead potential organ donors

Critical Care Medicine

Volumn 40, Issue 5, 2012, Pages 1635-1644

  MacDonald, Peter S ^a   Aneman, Anders ^b,g   Bhonagiri, Deepak ^b,g   Jones, Daryl ^c   O'Callaghan, Gerry ^d,g   Silvester, William ^c,g   Watson, Alasdair ^a   Dobb, Geoffrey ^e,f  

^a ST VINCENT S HOSPITAL   (Australia)

^b LIVERPOOL HOSPITAL   (Australia)

^c AUSTIN HOSPITAL   (Australia)

^d FLINDERS MEDICAL CENTRE   (Australia)

^e ROYAL PERTH HOSPITAL   (Australia)

^f UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^g Donate Life ^*  (Australia)

Author keywords

Donor management; thyoid hormone

Indexed keywords

HYDROCORTISONE; INSULIN; LIOTHYRONINE; METHYLPREDNISOLONE; PLACEBO; THYROID HORMONE; THYROXINE; VASOPRESSIN;

BRAIN DEATH; CONTROLLED STUDY; HEART INDEX; HORMONAL THERAPY; HUMAN; MEDLINE; META ANALYSIS; ORGAN DONOR; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PUBLICATION; RANDOMIZED CONTROLLED TRIAL; REVIEW; SYSTEMATIC REVIEW;

BRAIN DEATH; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; THYROID HORMONES; THYROXINE; TISSUE DONORS; TRIIODOTHYRONINE;

EID: 84860247145     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e3182416ee7     Document Type: Review

References (58)

1. Excell L, Hee K, Russ G: ANZOD Registry Report 2010. Adelaide, Australia and New Zealand Organ Donation Registry; 2010
2. Dimopoulou I, Tsagarakis S, Anthi A, et al: High prevalence of decreased cortisol reserve in brain-dead potential organ donors. Crit Care Med 2003; 31:1113-1117
3. Fitzgerald RD, Dechtyar I, Templ E, et al: Endocrine stress reaction to surgery in brain-dead organ donors. Transpl Int 1996; 9:102-108
4. Gramm HJ, Meinhold H, Bickel U, et al: Acute endocrine failure after brain death? Transplantation 1992; 54:851-857
5. Gravame V, Porretti L, Cardillo M, et al: [Hormone evaluation in brain death]. Minerva Anestesiol 1999; 65:725-731
6. Howlett TA, Keogh AM, Perry L, et al: Anterior and posterior pituitary function in brain-stemdead donors. A possible role for hormonal replacement therapy. Transplantation 1989; 47:828-834
7. Taniguchi S, Kitamura S, Kawachi K, et al: Effects of hormonal supplements on the maintenance of cardiac function in potential donor patients after cerebral death. Eur J Cardiothorac Surg 1992; 6:96-101; discussion 102
8. Gifford RR, Weaver AS, Burg JE, et al: Thyroid hormone levels in heart and kidney cadaver donors. J Heart Transplant 1986; 5:249-253
9. Goarin JP, Cohen S, Riou B, et al: The effects of triiodothyronine on hemodynamic status and cardiac function in potential heart donors. Anesth Analg 1996; 83:41-47
10. Karayalcin K, Umana JP, Harrison JD, et al: Donor thyroid function does not affect outcome in orthotopic liver transplantation. Transplantation 1994; 57:669-672
11. Koller J, Wieser C, Gottardis M, et al: Thyroid hormones and their impact on the hemodynamic and metabolic stability of organ donors and on kidney graft function after transplantation. Transplant Proc 1990; 22:355-357
12. Lopez Haldon J, Martinez Martinez A, Ordonez A, et al: [Hypothyroidism and myocardial damage in cardiac donors]. Rev Esp Cardiol 2001; 54:735-740
13. Masson F, Thicoipe M, Latapie MJ, et al: Thyroid function in brain-dead donors. Transpl Int 1990; 3:226-233
14. Powner DJ, Hendrich A, Lagler RG, et al: Hormonal changes in brain dead patients. Crit Care Med 1990; 18:702-708
15. Robertson KM, Hramiak IM, Gelb AW: Endocrine changes and haemodynamic stability after brain death. Transplant Proc 1989; 21(1 Pt 2):1197-1198
16. Powner DJ, Hernandez M: A review of thyroid hormone administration during adult donor care. Prog Transplant 2005; 15:202-207
17. Zaroff JG, Rosengard BR, Armstrong WF, et al: Consensus conference report: Maximizing use of organs recovered from the cadaver donor: Cardiac recommendations, March 28-29, 2001, Crystal City, Va. Circulation 2002; 106:836-841
18. Novitzky D, Cooper DK, Reichart B: Value of triiodothyronine (T3) therapy to brain-dead potential organ donors. J Heart Transplant 1986; 5:486-487
19. Novitzky D, Cooper DK, Reichart B: Hemodynamic and metabolic responses to hormonal therapy in brain-dead potential organ donors. Transplantation 1987; 43:852-854
20. Novitzky D, Cooper DK, Reichart B: The value of hormonal therapy in improving organ viability in the transplant donor. Transplant Proc 1987; 19(1 Pt 3):2037-2038
21. Novitzky D, Cooper DK, Human PA, et al: Triiodothyronine therapy for heart donor and recipient. J Heart Transplant 1988; 7:370-376
22. Novitzky D, Cooper DK, Chaffin JS, et al: Improved cardiac allograft function following triiodothyronine therapy to both donor and recipient. Transplantation 1990; 49:311-316
23. Garcia-Fages LC, Antolin M, Cabrer C, et al: Effects of substitutive triiodothyronine therapy on intracellular nucleotide levels in donor organs. Transplant Proc 1991; 23:2495-2496
24. Mariot J, Jacob F, Voltz C, et al: [Value of hormonal treatment with triiodothyronine and cortisone in brain dead patients]. Ann Fr Anesth Reanim 1991; 10:321-328
25. Randell TT, Hockerstedt KA: Triiodothyronine treatment in brain-dead multiorgan donors-a controlled study. Transplantation 1992; 54:736-738
26. Garcia-Fages LC, Cabrer C, Valero R, et al: Hemodynamic and metabolic effects of substitutive triiodothyronine therapy in organ donors. Transplant Proc 1993; 25:3038-3039
27. Jeevanandam V, Todd B, Hellman S, et al: Use of triiodothyronine replacement therapy to reverse donor myocardial dysfunction: Creating a larger donor pool. Transplant Proc 1993; 25:3305-3306
28. Orlowski JP, Spees EK: Improved cardiac transplant survival with thyroxine treatment of hemodynamically unstable donors: 95.2% graft survival at 6 and 30 months. Transplant Proc 1993, 25(1 Pt 2):1535
29. Randell TT, Hockerstedt KA: Triiodothyronine treatment is not indicated in brain-dead multiorgan donors: A controlled study. Transplant Proc 1993, 25(1 Pt 2):1552-1553
30. Wheeldon DR, Potter CD, Jonas M, et al: Transplantation of "unsuitable" organs? Transplant Proc 25(6):3104-3105, 1993
31. Jeevanandam V, Todd B, Regillo T, et al: Reversal of donor myocardial dysfunction by triiodothyronine replacement therapy. J Heart Lung Transplant 1994; 13:681-687, discussion 685-687
32. Jeevanandam V, Furukawa S, Prendergast TW, et al: Standard criteria for an acceptable donor heart are restricting heart transplantation. Ann Thorac Surg 1996; 62:1268-1275
33. Jeevanandam V: Triiodothyronine: spectrum of use in heart transplantation. Thyroid 1997; 7:139-145
34. Roels L, Pirenne J, Delooz H, et al: Effect of triiodothyronine replacement therapy on maintenance characteristics and organ availability in hemodynamically unstable donors. Transplant Proc 2000; 32:1564-1566
35. Salim A, Vassiliu P, Velmahos GC, et al: The role of thyroid hormone administration in potential organ donors. Arch Surg 2001; 136:1377-1380
36. Rosendale JD, Kauffman HM, McBride MA, et al: Hormonal resuscitation yields more transplanted hearts, with improved early function. Transplantation 2003; 75:1336-1341
37. Rosendale JD, Kauffman HM, McBride MA, et al Aggressive pharmacologic donor management results in more transplanted organs. Transplantation 2003; 75:482-487
38. Van Bakel AB, Pitzer S, Drake P, et al: Early hormonal therapy stabilizes hemodynamics during donor procurement. Transplant Proc 2004; 36:2573-2578
39. Zuppa AF, Nadkarni V, Davis L, et al: The effect of a thyroid hormone infusion on vasopressor support in critically ill children with cessation of neurologic function. Crit Care Med 2004; 32:2318-2322
40. Perez-Blanco A, Caturla-Such J, Canovas-Robles J, et al: Efficiency of triiodothyronine treatment on organ donor hemodynamic management and adenine nucleotide concentration. Intensive Care Med 2005; 31:943-948
41. Salim A, Velmahos GC, Brown C, et al: Aggressive organ donor management significantly increases the number of organs available for transplantation. J Trauma 2005; 58:991-994
42. Salim A, Martin M, Brown C, et al: Using thyroid hormone in brain-dead donors to maximize the number of organs available for transplantation. Clin Transplant 2007; 21:405-409
43. Venkateswaran RV, Patchell VB, Wilson IC, et al: Early donor management increases the retrieval rate of lungs for transplantation. Ann Thorac Surg 2008; 85:278-286, discussion 286
44. Abdelnour T, Rieke S: Relationship of hormonal resuscitation therapy and central venous pressure on increasing organs for transplant. J Heart Lung Transplant 2009; 28:480-485
45. Venkateswaran RV, Dronavalli V, Lambert PA, et al: The proinflammatory environment in potential heart and lung donors: Prevalence and impact of donor management and hormonal therapy. Transplantation 2009; 88:582-588
46. Venkateswaran RV, Ganesh JS, Thekkudan J, et al: Donor cardiac troponin-I: A biochemical surrogate of heart function. Eur J Cardiothorac Surg 2009; 36:286-292, discussion 292
47. Venkateswaran RV, Steeds RP, Quinn DW, et al: The haemodynamic effects of adjunctive hormone therapy in potential heart donors: A prospective randomized double-blind factorially designed controlled trial. Eur Heart J 2009; 30(14):1771-1780
48. James SR, Ranasinghe AM, Venkateswaran R, et al: The effects of acute triiodothyronine therapy on myocardial gene expression in brain stem dead cardiac donors. J Clin Endocrinol Metab 2010; 95:1338-1343
49. Nath DS, Ilias Basha H, Liu MH, et al: Increased recovery of thoracic organs after hormonal resuscitation therapy. J Heart Lung Transplant 2010; 29:594-596
50. Venkateswaran RV, Townend JN, Wilson IC, et al: Echocardiography in the potential heart donor. Transplantation 2010; 89:894-901
51. Wheeldon DR, Potter CD, Jonas M, et al: Using "unsuitable" hearts for transplantation. Eur J Cardiothorac Surg 1994; 8:7-9, discussion 10-11
52. Wheeldon DR, Potter CD, Oduro A, et al: Transforming the "unacceptable" donor: Outcomes from the adoption of a standardized donor management technique. J Heart Lung Transplant 1995; 14:734-742
53. National Health and Medical Research Council. Canberra: A guide to the development, implementation and evaluation of clinical practice guidelines. 1999 p56. Available at: http://www.nhmrc.gov.au/-files-nhmrc/publications/ attachments/cp30.pdf. Accessed December 7, 2011
54. Jadad AR, Moore RA, Carroll D, et al: Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Control Clin Trials 1996; 17:1-12
55. Zaroff JG, Babcock WD, Shiboski SC, et al: Temporal changes in left ventricular systolic function in heart donors: Results of serial echocardiography. J Heart Lung Transplant 2003; 22:383-388
56. Orlowski JP: Evidence that thyroxine (T-4) is effective as a hemodynamic rescue agent in management of organ donors. Transplantation 1993; 55:959-960
57. Novitzky D, Cooper DK, Rosendale JD, et al: Hormonal therapy of the brain-dead organ donor: Experimental and clinical studies. Transplantation 2006; 82:1396-1401
58. Cooper DK, Novitzky D, Wicomb WN, et al: A review of studies relating to thyroid hormone therapy in brain-dead organ donors. Front Biosci 2009; 14:3750-3770